Additionally, in 2014, Chan et al. published a meta-analysis of 48 case-control studies [4] and confirmed that the frequency of heterozygotes for a truncating GJB2 variant (monoallelic) among patients with hearing loss is twice as high when compared to the normal-hearing population. This evidence concerns the gene GJB2 and hearing loss disorder.